Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_assertion type Assertion NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_head.
- NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_assertion description "[Over this 2 hr period, 10 of 24 patients (responders) demonstrated 25% or greater improvement in the extent of pulmonary artery thrombus as quantified by Urokinase Pulmonary Embolism Trial score, and these patients were found to have a significantly lower XDP/FDP ratio after rt-PA (p less than .04) than those patients who failed to respond.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_provenance.
- NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_assertion evidence source_evidence_curated NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_provenance.
- NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_assertion SIO_000772 3105914 NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_provenance.
- NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_assertion wasDerivedFrom ctd_human-20130708 NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_provenance.
- NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_assertion wasGeneratedBy ECO_0000218 NP26173.RAwXop0-ceHc4zg1LaBSJmT-htlcnRuYRn328iZbm598s130_provenance.